US pharmaceutical giant Pfizer has said it would sell its patented drugs on a not-for-profit basis to the world’s poorest countries, as part of a new initiative announced at the World Economic Forum in Davos.
“The time is now to begin closing this gap” between people with access to the latest treatments and those going without, chief executive Albert Bourla told attendees at the Swiss mountain resort gathering on Wednesday.
“What we discovered through the pandemic was that supply was not enough to resolve the issues that these countries are having,” Bourla said.
He noted that billions of doses of the company’s COVID-19 vaccine, Comirnaty, have been offered for free to low-income countries, mainly through the US government, but those doses cannot be used right now.
“An Accord for a Healthier World” focuses on five areas: infectious diseases, cancer, inflammation, rare diseases and women’s health – where Pfizer currently holds 23 patents, including the likes of Comirnaty and Paxlovid, its COVID vaccine and oral treatment.
Bütün xəbərlər Facebook səhifəmizdə
USD
EUR
GBP
RUB
